$Novavax(NVAX)$, the new vaccine against Omicron in Italy
The current structure of Novavax provides for a double dose, which is administered at intervals of one month. The mechanism of the drug is very simple: by reclining part of the protein material of the virus, the vaccine guarantees immunity and protection to the organism.
The technology is therefore the most widespread for gender drugs. The indications on the studies carried out for Novavax give 90% protection from infection. Furthermore, the possibility of a third booster dose, six months after the first cycle, is also being evaluated for this vaccine.
The fight against Covid is strongly back in the news during these first days of the new year, also thanks to the Omicron variant which is causing a new wave of infections. One more tool for the community could be the fifth EMA-approved vaccine: Novavax. The serum will soon be available also in Italy. Compared to Pfizer or Moderna which use mRNA technology, Novavax's principle is that of a protein-based vaccine.
I believe their newly developed products will make great achievements.
Comments